Navigation Links
Novel handheld device detects anthrax with outstanding accuracy and reliability
Date:7/8/2009

ction approaches require longer and more complex processing to distinguish anthrax from other substances (between 30 minutes and three days), their accuracy is inferior to the Ceeker and the sample is typically destroyed during testing.

The new data will be presented on June 26, 2009 at Biodetection Technologies 2009 by Professor Lou Reinisch, an inventor of the Ceeker technology and Professor of Physics and Department Head at Jacksonville State University in Alabama. Prof. Reinisch noted, "It is gratifying to present these outstanding results from a system that has so much potential to reduce the large costs and losses in productivity and peace of mind caused by our current inability to easily distinguish between anthrax spores and harmless white powder. These new data definitively confirm the validity of the detection concepts underlying the Ceeker and should help fuel its wider use among such first responders as fire and police departments, HazMat teams, postal services, port and airport security, and defense and military authorities."

John Delaney is Captain, Arlington County, Virginia Fire Department and Manager, National Medical Response Team-National Capital Region, home to the Pentagon and many other major U.S. government and corporate facilities. Capt. Delaney commented, "With responsibility for helping to ensure the safety of the hundreds of thousands of people who live and work in the Capital Region, my department welcomes the availability of technologically advanced solutions that enhance our ability to carry out our mission. The Veritide Ceeker is an excellent exampleit is extremely versatile, easy-to-use and fastresults are ready in minutes. Most importantly, the new test data being presented this week confirm that the Ceeker is very reliable, enabling front-line decision makers to rapidly and confidently validate initial threat assessments that can ultimately have a far-reaching impact on public safety and well-being. The Natio
'/>"/>

Contact: Barbara Lindheim
212-918-4650
BioCom Partners
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Novel Technology Breaks Through Cancer Pain
2. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
3. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
4. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
5. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
6. NIST team develops novel method for nanostructured polymer thin films
7. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
8. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
9. European Expert Consortium Combines Forces to Develop a Novel Pandemic Influenza Vaccine
10. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
11. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
Post Your Comments:
*Name:
*Comment:
*Email: